Black Diamond Therapeutics, Inc.
USD2.18
-0.08 (-3.54%)
CEO
Mark A. Velleca
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.23
Prev. Close
$2.26
Day Low
$2.17
Day High
$2.27
52W Low
$1.93
52W High
$4.94
Market Cap
$0.12B
Volume
1.36M
| 6,105 |
| $2.15 |
| 23 Jan 2026 | Jones Erika | SEE REMARKS | A-Award | Acquired | 200,000 | $2.57 |
| 23 Jan 2026 | Hatzis-Schoch Brent | SEE REMARKS | A-Award | Acquired | 250,000 | $2.57 |
| 23 Jan 2026 | Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | A-Award | Acquired | 250,000 | $2.57 |
| 23 Jan 2026 | Yurasov Sergey | CHIEF MEDICAL OFFICER | A-Award | Acquired | 250,000 | $2.57 |
| 23 Jan 2026 | Velleca Mark A. | director, officer: PRESIDENT & CEO | A-Award | Acquired | 600,000 | $2.57 |
| 15 Dec 2025 | Behbahani Ali | director | A-Award | Acquired | 5,208 | $2.76 |
| 15 Dec 2025 | Raman Prakash | director | A-Award | Acquired | 4,665 | $2.76 |
| 22 Sept 2025 | Behbahani Ali | director | A-Award | Acquired | 4,291 | $3.35 |